vs
Ranpak Holdings Corp.（PACK）与PUMA BIOTECHNOLOGY, INC.（PBYI）财务数据对比。点击上方公司名可切换其他公司
Ranpak Holdings Corp.的季度营收约是PUMA BIOTECHNOLOGY, INC.的1.2倍（$93.7M vs $75.5M），PUMA BIOTECHNOLOGY, INC.同比增速更快（27.7% vs 2.3%），过去两年PUMA BIOTECHNOLOGY, INC.的营收复合增速更高（31.3% vs 13.7%）
Ranpak Holdings Corp.主营生产防护纸质包装设备与纸制品，可为电商及各行业货品运输提供纸质缓冲包装方案，同时也供应自动化包装解决方案。公司总部位于美国俄亥俄州康科德，在美国本土多个州、捷克、荷兰、中国上海及新加坡均设有生产基地与办公室，产品可用于包裹缠绕、缓冲填隙、冷链运输等多种场景。
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
PACK vs PBYI — 直观对比
营收规模更大
PACK
是对方的1.2倍
$75.5M
营收增速更快
PBYI
高出25.4%
2.3%
两年增速更快
PBYI
近两年复合增速
13.7%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $93.7M | $75.5M |
| 净利润 | — | — |
| 毛利率 | 39.0% | 69.3% |
| 营业利润率 | -1.0% | 22.7% |
| 净利率 | — | — |
| 营收同比 | 2.3% | 27.7% |
| 净利润同比 | — | — |
| 每股收益（稀释后） | $-0.11 | $0.26 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PACKPBYI
| Q4 25 | $93.7M | $75.5M | ||
| Q3 25 | $83.6M | $54.5M | ||
| Q2 25 | $77.8M | $52.4M | ||
| Q1 25 | $77.6M | $46.0M | ||
| Q4 24 | $91.6M | $59.1M | ||
| Q3 24 | $78.6M | $80.5M | ||
| Q2 24 | $72.8M | $47.1M | ||
| Q1 24 | $72.5M | $43.8M |
净利润PACKPBYI
| Q4 25 | — | — | ||
| Q3 25 | $-10.4M | $8.8M | ||
| Q2 25 | $-7.5M | $5.9M | ||
| Q1 25 | $-10.9M | $3.0M | ||
| Q4 24 | — | — | ||
| Q3 24 | $-8.1M | $20.3M | ||
| Q2 24 | $5.5M | $-4.5M | ||
| Q1 24 | $-8.1M | $-4.8M |
毛利率PACKPBYI
| Q4 25 | 39.0% | 69.3% | ||
| Q3 25 | 41.1% | 77.7% | ||
| Q2 25 | 37.1% | 76.5% | ||
| Q1 25 | 39.8% | 77.1% | ||
| Q4 24 | 45.2% | 76.4% | ||
| Q3 24 | 43.8% | 63.9% | ||
| Q2 24 | 43.5% | 77.4% | ||
| Q1 24 | 44.6% | 75.5% |
营业利润率PACKPBYI
| Q4 25 | -1.0% | 22.7% | ||
| Q3 25 | -6.8% | 17.6% | ||
| Q2 25 | -12.5% | 12.7% | ||
| Q1 25 | -10.3% | 8.7% | ||
| Q4 24 | 1.5% | 22.6% | ||
| Q3 24 | -5.3% | 27.4% | ||
| Q2 24 | -7.1% | -4.6% | ||
| Q1 24 | -6.6% | -5.3% |
净利率PACKPBYI
| Q4 25 | — | — | ||
| Q3 25 | -12.4% | 16.2% | ||
| Q2 25 | -9.6% | 11.2% | ||
| Q1 25 | -14.0% | 6.5% | ||
| Q4 24 | — | — | ||
| Q3 24 | -10.3% | 25.2% | ||
| Q2 24 | 7.6% | -9.6% | ||
| Q1 24 | -11.2% | -11.0% |
每股收益（稀释后）PACKPBYI
| Q4 25 | $-0.11 | $0.26 | ||
| Q3 25 | $-0.12 | $0.17 | ||
| Q2 25 | $-0.09 | $0.12 | ||
| Q1 25 | $-0.13 | $0.06 | ||
| Q4 24 | $-0.13 | $0.40 | ||
| Q3 24 | $-0.10 | $0.41 | ||
| Q2 24 | $0.07 | $-0.09 | ||
| Q1 24 | $-0.10 | $-0.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $63.0M | $97.5M |
| 总债务越低越好 | $401.9M | $22.7M |
| 股东权益账面价值 | $534.9M | $130.3M |
| 总资产 | $1.1B | $216.3M |
| 负债/权益比越低杠杆越低 | 0.75× | 0.17× |
8季度趋势，按日历期对齐
现金及短期投资PACKPBYI
| Q4 25 | $63.0M | $97.5M | ||
| Q3 25 | $49.9M | $94.4M | ||
| Q2 25 | $49.2M | $96.0M | ||
| Q1 25 | $65.5M | $93.2M | ||
| Q4 24 | $76.1M | $101.0M | ||
| Q3 24 | $69.5M | $96.7M | ||
| Q2 24 | $65.1M | $96.8M | ||
| Q1 24 | $55.1M | $107.2M |
总债务PACKPBYI
| Q4 25 | $401.9M | $22.7M | ||
| Q3 25 | $403.1M | $34.0M | ||
| Q2 25 | $403.1M | $45.3M | ||
| Q1 25 | $405.2M | $56.7M | ||
| Q4 24 | $406.4M | $68.0M | ||
| Q3 24 | $403.2M | $79.3M | ||
| Q2 24 | $396.1M | $90.7M | ||
| Q1 24 | $396.7M | $102.0M |
股东权益PACKPBYI
| Q4 25 | $534.9M | $130.3M | ||
| Q3 25 | $537.8M | $115.3M | ||
| Q2 25 | $539.0M | $104.7M | ||
| Q1 25 | $544.1M | $97.1M | ||
| Q4 24 | $548.1M | $92.1M | ||
| Q3 24 | $564.3M | $71.1M | ||
| Q2 24 | $566.2M | $48.5M | ||
| Q1 24 | $560.0M | $51.0M |
总资产PACKPBYI
| Q4 25 | $1.1B | $216.3M | ||
| Q3 25 | $1.1B | $202.9M | ||
| Q2 25 | $1.1B | $194.9M | ||
| Q1 25 | $1.1B | $196.2M | ||
| Q4 24 | $1.1B | $213.3M | ||
| Q3 24 | $1.1B | $220.7M | ||
| Q2 24 | $1.1B | $205.0M | ||
| Q1 24 | $1.1B | $214.1M |
负债/权益比PACKPBYI
| Q4 25 | 0.75× | 0.17× | ||
| Q3 25 | 0.75× | 0.30× | ||
| Q2 25 | 0.75× | 0.43× | ||
| Q1 25 | 0.74× | 0.58× | ||
| Q4 24 | 0.74× | 0.74× | ||
| Q3 24 | 0.71× | 1.12× | ||
| Q2 24 | 0.70× | 1.87× | ||
| Q1 24 | 0.71× | 2.00× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $19.5M | $14.4M |
| 自由现金流经营现金流 - 资本支出 | — | $14.4M |
| 自由现金流率自由现金流/营收 | — | 19.1% |
| 资本支出强度资本支出/营收 | — | 0.0% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $41.7M |
8季度趋势，按日历期对齐
经营现金流PACKPBYI
| Q4 25 | $19.5M | $14.4M | ||
| Q3 25 | $8.5M | $9.7M | ||
| Q2 25 | $-3.6M | $14.1M | ||
| Q1 25 | $-1.3M | $3.6M | ||
| Q4 24 | $6.5M | $15.6M | ||
| Q3 24 | $10.1M | $11.0M | ||
| Q2 24 | $19.6M | $1.0M | ||
| Q1 24 | $5.2M | $11.2M |
自由现金流PACKPBYI
| Q4 25 | — | $14.4M | ||
| Q3 25 | — | $9.7M | ||
| Q2 25 | — | $14.1M | ||
| Q1 25 | — | $3.6M | ||
| Q4 24 | — | $15.6M | ||
| Q3 24 | — | $11.0M | ||
| Q2 24 | — | $1.0M | ||
| Q1 24 | — | — |
自由现金流率PACKPBYI
| Q4 25 | — | 19.1% | ||
| Q3 25 | — | 17.7% | ||
| Q2 25 | — | 26.8% | ||
| Q1 25 | — | 7.7% | ||
| Q4 24 | — | 26.4% | ||
| Q3 24 | — | 13.7% | ||
| Q2 24 | — | 2.1% | ||
| Q1 24 | — | — |
资本支出强度PACKPBYI
| Q4 25 | — | 0.0% | ||
| Q3 25 | — | 0.0% | ||
| Q2 25 | — | 0.0% | ||
| Q1 25 | — | 0.1% | ||
| Q4 24 | — | 0.0% | ||
| Q3 24 | — | 0.0% | ||
| Q2 24 | — | 0.0% | ||
| Q1 24 | — | 0.0% |
现金转化率PACKPBYI
| Q4 25 | — | — | ||
| Q3 25 | — | 1.10× | ||
| Q2 25 | — | 2.41× | ||
| Q1 25 | — | 1.21× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.54× | ||
| Q2 24 | 3.56× | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
PACK
| Other | $47.9M | 51% |
| Europe And Asia Segment | $45.8M | 49% |
PBYI
暂无分部数据
